Veterinary Medicines

Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs

Not authorised
  • DL-ALPHA TOCOPHEROL ACETATE
  • COLECALCIFEROL CONCENTRATE (OILY FORM)
  • Retinol palmitate
Download as PDF

Product identification

Medicine name:
Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Vitamin AD3E, Injektionslösung für Rind, Pferd, Schwein und Hund
Active substance:
  • DL-ALPHA TOCOPHEROL ACETATE
  • COLECALCIFEROL CONCENTRATE (OILY FORM)
  • Retinol palmitate
Target species:
  • Cattle
  • Dog
  • Horse
  • Pig
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • DL-ALPHA TOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • COLECALCIFEROL CONCENTRATE (OILY FORM)
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    176.46
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        120
        hour
      • Meat and offal
        259
        day
    • Dog
    • Horse
      • Meat and offal
        250
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        194
        day
  • Intramuscular use
    • Cattle
      • Milk
        120
        hour
      • Meat and offal
        259
        day
    • Dog
    • Horse
      • Meat and offal
        250
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        194
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Medicinal product on medical prescription for renewable delivery
Authorisation status:
  • Revoked
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 839012
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0313/001

Documents

Combined File of all Documents

English (PDF)
Published on: 15/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 7/12/2021
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 7/12/2021
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 7/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."